Charles River Laboratories International (CRL) Finished Goods (2010 - 2022)
Charles River Laboratories International (CRL) posted Finished Goods of $184.6 million for Q3 2022, up 4.92% on a QoQ basis from $175.9 million in Q2 2022, and up 51.28% year-over-year from $122.0 million in Q3 2021.
Analysis
Charles River Laboratories International (CRL) Finished Goods (2010 - 2022) Analysis & Trends
Charles River Laboratories International has reported Finished Goods for 13 years, with the latest figure at $184.6 million in Q3 2022.
- On a quarterly basis, Finished Goods rose 51.28% year-over-year to $184.6 million in Q3 2022; TTM through Sep 2022 was $184.6 million, a 51.28% increase from a year earlier, with the FY2021 full-year figure at $125.8 million, up 4.26% from the prior year.
- Finished Goods was $184.6 million for Q3 2022 at Charles River Laboratories International, up from $175.9 million in the prior quarter.
- The five-year high for Finished Goods was $184.6 million in Q3 2022, with the low at $79.6 million in Q1 2018.
- Average Finished Goods over 5 years is $114.6 million, with a median of $107.1 million recorded in 2020.
- The sharpest annual moves came in 2021 and 2022: Finished Goods climbed 4.26% in 2021, then surged 51.28% in 2022.
- Over 5 years, Finished Goods stood at $83.8 million in 2018, then climbed by 19.59% to $100.2 million in 2019, then grew by 20.39% to $120.6 million in 2020, then increased by 4.26% to $125.8 million in 2021, then jumped by 46.76% to $184.6 million in 2022.
- The last three Finished Goods figures came in at $184.6 million (Q3 2022), $175.9 million (Q2 2022), and $150.8 million (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 24, 2022 | 184.57 Mn |
| Jun 25, 2022 | 175.91 Mn |
| Mar 26, 2022 | 150.76 Mn |
| Dec 25, 2021 | 125.76 Mn |
| Sep 25, 2021 | 122.00 Mn |
| Jun 26, 2021 | 133.96 Mn |
| Mar 27, 2021 | 134.24 Mn |
| Dec 26, 2020 | 120.62 Mn |
| Jun 27, 2020 | 106.32 Mn |
| Mar 28, 2020 | 107.81 Mn |
| Dec 28, 2019 | 100.20 Mn |
| Sep 28, 2019 | 95.01 Mn |
| Jun 29, 2019 | 87.53 Mn |
| Mar 30, 2019 | 86.94 Mn |
| Dec 29, 2018 | 83.78 Mn |
| Sep 29, 2018 | 84.47 Mn |
| Jun 30, 2018 | 82.89 Mn |
| Mar 31, 2018 | 79.61 Mn |
| Dec 30, 2017 | 76.90 Mn |
| Sep 30, 2017 | 74.95 Mn |